OpenAIRE | Search for Research Products

Research products (201)
Projects (0)
Data sources (0)
Organizations (0)

201 Research products for Alkoclar

Results per page

arrow_drop_down

Sort by

Relevance

arrow_drop_down

Erdal Can Alkoclar
Research datakeyboard_double_arrow_right Dataset 2019ICPSR - Interuniversity Consortium for Political and Social Research
Authors: Erdal Can Alkoclar;
Erdal Can Alkoclar;
doi: 10.3886/e109942 , 10.3886/e109942v1
doi: 10.3886/e109942 , 10.3886/e109942v1
An Antiviral Formulation consisting of 3 1-ProtopanaxatriolAnalouges with Simultenaous DNA Polymerase and Ribonucleotide ReductaseSuppressive Properties
Inter-university Con...arrow_drop_down
Inter-university Consortium for Political and Social Research
Dataset . 2019
Data sources: Datacite
Inter-university Consortium for Political and Social Research
Dataset . 2019
Data sources: Datacite; ORCID
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Inter-university Con...arrow_drop_down
Inter-university Consortium for Political and Social Research
Dataset . 2019
Data sources: Datacite
Inter-university Consortium for Political and Social Research
Dataset . 2019
Data sources: Datacite; ORCID
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A Thyrogenic Formula for the Treatment of Hypothyroidism
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/sedt5
doi: 10.17605/osf.io/sedt5
A Thyrogenic Formula that consists A Pro-Dopaminergic Tyrosol Glucoside; A Thyrogenic Diosgenin Analouge and an Adrenal Androgen Precursor. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yesil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A Formulation with Tissue Regeneration Enhancing Properties
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/kng46
doi: 10.17605/osf.io/kng46
A Formula with Simultenaous VEGF IGF-1 and AMPK mRNA Expression Enhancement Features. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Erdal Can Alkoclar & Metehan Yesil Patented GBTU CLass Formulation Abstracts
descriptionPublicationkeyboard_double_arrow_right Article 2023 English Zenodo
Authors: Alkoclar; Yesil;
Alkoclar; Yesil;
doi: 10.5281/zenodo.7977833 , 10.5281/zenodo.7977832
doi: 10.5281/zenodo.7977833 , 10.5281/zenodo.7977832
205 PATENTED FORMULATIONS LISTED IN THIS PROJECT INCLUDES BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, Hıf-10 SUPPRESSIVE AGENTS, TNF-A & NF-KAPPA B COX-2 INTERLEUKIN-6 SUPPRESSIVE AND IMMUNOMODULATIVE AGENTS FOR AUTOIMMUNE DISEASES, FMO3 SUPPRESSIVE ANALGESIC AGENTS, THYROGENIC & THYROMODULATORY AGENTS, RNA POLYMERASE & DNA POLYMERASE & VIRAL DNA GYRASE SUPPRESSIVE ANTIVIRAL AGENTS, TOPOISOMERASE I & II, RIBONUCLEOTIDE REDUCTASE SUPPRESSIVE ANTIBACTERIAL AGENTS, GLUT4 TRANSLOCATIVE ANTIDIABETIC AGENTS AND MANY OTHER INNOVATIVE FORMULATIONS WITH NOVEL MECHANISMS OF ACTION. Erdal Can ALKOCLAR & Metehan YESIL
ZENODOarrow_drop_down
ZENODO
Article . 2023
License: https://creativecommons.org/licenses/by/4.0/legalcode
Data sources: Datacite
ZENODO
Article . 2023
License: http://creativecommons.org/licenses/by/4.0/legalcode
Data sources: ZENODO
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
ZENODOarrow_drop_down
ZENODO
Article . 2023
License: https://creativecommons.org/licenses/by/4.0/legalcode
Data sources: Datacite
ZENODO
Article . 2023
License: http://creativecommons.org/licenses/by/4.0/legalcode
Data sources: ZENODO
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
An Ergogenic Formulation with Athletic Performance Enhancing Features
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/mc72b
doi: 10.17605/osf.io/mc72b
An Anti-Asthenic and Ergogenic Formula with Athletic Performance Enhancing Features; To Prolong the Active Lifestyle Phase of the Elderly. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
An Anti-Addiction Formula with Catecholamine Suppressive and Pro-Serotonergic Features
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/4aufw
doi: 10.17605/osf.io/4aufw
An Anti-Addiction Formula with DHEA secretion Enhancing Partial Pro-Dopaminergic and Serotonin Elevating Properties along with Adrenaline Suppression. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A Nootropic Formula for the Treatment of Attention Deficit Disorder
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/wdkrh
doi: 10.17605/osf.io/wdkrh
A Nootropic Formulation with Pro-Cholinergic Dopamine and Serotonin Receptoral Sensitivity Enhancement Features along with the elevation of Beta-Endorphin Release. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
An Antiviral Formula with Reverse Transcriptase and DNA Gyrase Suppressive Features
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/sgr3p
doi: 10.17605/osf.io/sgr3p
An Antiviral Formula Consisting of Protopanaxatriol Derivatives with Rapid Onset Antiviral Action MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A Pro-Somatotrophic Formulation with GH and T3 mRNA Expression Enhancement Properties
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/26vy5
doi: 10.17605/osf.io/26vy5
A Pro-Somathropic Formula that simultaneously exhibits Pro-Thyrogenic Features ; The Crucial Role of T3 on IGF-1 mRNA Expression / Proliferation MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A Novel Anti-Inflammatory Formula with FMO3 and Substance P Suppressive Properties
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/xmdru
doi: 10.17605/osf.io/xmdru
A Novel Anti-Inflammatory Formula that exerts FMO3 Expression Inhibitive Properties Along with COX-2 and Nf-Kappa B Suppression. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

201 Research products for Alkoclar

Erdal Can Alkoclar
Research datakeyboard_double_arrow_right Dataset 2019ICPSR - Interuniversity Consortium for Political and Social Research
Authors: Erdal Can Alkoclar;
Erdal Can Alkoclar;
doi: 10.3886/e109942 , 10.3886/e109942v1
doi: 10.3886/e109942 , 10.3886/e109942v1
An Antiviral Formulation consisting of 3 1-ProtopanaxatriolAnalouges with Simultenaous DNA Polymerase and Ribonucleotide ReductaseSuppressive Properties
Inter-university Con...arrow_drop_down
Inter-university Consortium for Political and Social Research
Dataset . 2019
Data sources: Datacite
Inter-university Consortium for Political and Social Research
Dataset . 2019
Data sources: Datacite; ORCID
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Inter-university Con...arrow_drop_down
Inter-university Consortium for Political and Social Research
Dataset . 2019
Data sources: Datacite
Inter-university Consortium for Political and Social Research
Dataset . 2019
Data sources: Datacite; ORCID
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A Thyrogenic Formula for the Treatment of Hypothyroidism
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/sedt5
doi: 10.17605/osf.io/sedt5
A Thyrogenic Formula that consists A Pro-Dopaminergic Tyrosol Glucoside; A Thyrogenic Diosgenin Analouge and an Adrenal Androgen Precursor. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yesil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A Formulation with Tissue Regeneration Enhancing Properties
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/kng46
doi: 10.17605/osf.io/kng46
A Formula with Simultenaous VEGF IGF-1 and AMPK mRNA Expression Enhancement Features. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Erdal Can Alkoclar & Metehan Yesil Patented GBTU CLass Formulation Abstracts
descriptionPublicationkeyboard_double_arrow_right Article 2023 English Zenodo
Authors: Alkoclar; Yesil;
Alkoclar; Yesil;
doi: 10.5281/zenodo.7977833 , 10.5281/zenodo.7977832
doi: 10.5281/zenodo.7977833 , 10.5281/zenodo.7977832
205 PATENTED FORMULATIONS LISTED IN THIS PROJECT INCLUDES BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, Hıf-10 SUPPRESSIVE AGENTS, TNF-A & NF-KAPPA B COX-2 INTERLEUKIN-6 SUPPRESSIVE AND IMMUNOMODULATIVE AGENTS FOR AUTOIMMUNE DISEASES, FMO3 SUPPRESSIVE ANALGESIC AGENTS, THYROGENIC & THYROMODULATORY AGENTS, RNA POLYMERASE & DNA POLYMERASE & VIRAL DNA GYRASE SUPPRESSIVE ANTIVIRAL AGENTS, TOPOISOMERASE I & II, RIBONUCLEOTIDE REDUCTASE SUPPRESSIVE ANTIBACTERIAL AGENTS, GLUT4 TRANSLOCATIVE ANTIDIABETIC AGENTS AND MANY OTHER INNOVATIVE FORMULATIONS WITH NOVEL MECHANISMS OF ACTION. Erdal Can ALKOCLAR & Metehan YESIL
ZENODOarrow_drop_down
ZENODO
Article . 2023
License: https://creativecommons.org/licenses/by/4.0/legalcode
Data sources: Datacite
ZENODO
Article . 2023
License: http://creativecommons.org/licenses/by/4.0/legalcode
Data sources: ZENODO
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
ZENODOarrow_drop_down
ZENODO
Article . 2023
License: https://creativecommons.org/licenses/by/4.0/legalcode
Data sources: Datacite
ZENODO
Article . 2023
License: http://creativecommons.org/licenses/by/4.0/legalcode
Data sources: ZENODO
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
An Ergogenic Formulation with Athletic Performance Enhancing Features
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/mc72b
doi: 10.17605/osf.io/mc72b
An Anti-Asthenic and Ergogenic Formula with Athletic Performance Enhancing Features; To Prolong the Active Lifestyle Phase of the Elderly. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
An Anti-Addiction Formula with Catecholamine Suppressive and Pro-Serotonergic Features
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/4aufw
doi: 10.17605/osf.io/4aufw
An Anti-Addiction Formula with DHEA secretion Enhancing Partial Pro-Dopaminergic and Serotonin Elevating Properties along with Adrenaline Suppression. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A Nootropic Formula for the Treatment of Attention Deficit Disorder
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/wdkrh
doi: 10.17605/osf.io/wdkrh
A Nootropic Formulation with Pro-Cholinergic Dopamine and Serotonin Receptoral Sensitivity Enhancement Features along with the elevation of Beta-Endorphin Release. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
An Antiviral Formula with Reverse Transcriptase and DNA Gyrase Suppressive Features
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/sgr3p
doi: 10.17605/osf.io/sgr3p
An Antiviral Formula Consisting of Protopanaxatriol Derivatives with Rapid Onset Antiviral Action MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
0
citations 0
popularity Average
influence Average
impulse Average
Powered by BIP!
more_vert
Open Science Framewo...arrow_drop_down
Open Science Framework
Other literature type . 2022
Data sources: Datacite
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A Pro-Somatotrophic Formulation with GH and T3 mRNA Expression Enhancement Properties
descriptionPublicationkeyboard_double_arrow_right Other literature type 2022Open Science Framework
Authors: Alkoclar, Erdal;
Alkoclar, Erdal;
doi: 10.17605/osf.io/26vy5

Filters

Access (1)

Type (4)

Year range

Funder (1)

SDG [Beta] (1)

Country (2)

Language (1)

Source (12)

Research community (4)

Erdal Can Alkoclar

A Thyrogenic Formula for the Treatment of Hypothyroidism

A Formulation with Tissue Regeneration Enhancing Properties

Erdal Can Alkoclar & Metehan Yesil Patented GBTU CLass Formulation Abstracts

An Ergogenic Formulation with Athletic Performance Enhancing Features

An Anti-Addiction Formula with Catecholamine Suppressive and Pro-Serotonergic Features

A Nootropic Formula for the Treatment of Attention Deficit Disorder

An Antiviral Formula with Reverse Transcriptase and DNA Gyrase Suppressive Features

A Pro-Somatotrophic Formulation with GH and T3 mRNA Expression Enhancement Properties

A Novel Anti-Inflammatory Formula with FMO3 and Substance P Suppressive Properties

Erdal Can Alkoclar

A Thyrogenic Formula for the Treatment of Hypothyroidism

A Formulation with Tissue Regeneration Enhancing Properties

Erdal Can Alkoclar & Metehan Yesil Patented GBTU CLass Formulation Abstracts

An Ergogenic Formulation with Athletic Performance Enhancing Features

An Anti-Addiction Formula with Catecholamine Suppressive and Pro-Serotonergic Features

A Nootropic Formula for the Treatment of Attention Deficit Disorder

An Antiviral Formula with Reverse Transcriptase and DNA Gyrase Suppressive Features

A Pro-Somatotrophic Formulation with GH and T3 mRNA Expression Enhancement Properties

	citations	0
	popularity	Average
	influence	Average
	impulse	Average

	citations	0
	popularity	Average
	influence	Average
	impulse	Average

	citations	0
	popularity	Average
	influence	Average
	impulse	Average

	citations	0
	popularity	Average
	influence	Average
	impulse	Average

Filters

Access (1)

Type (4)

Year range

Funder (1)

SDG [Beta] (1)

Country (2)

Language (1)

Source (12)

Research community (4)

Loading